ArticleGynecologic oncology2026
Symptom-related care and diagnoses before ovarian cancer detection: Patterns and differences by cancer stage.
Article in Gynecologic oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diagnostic Timing and Ovarian Cancer Survival.JAMA network open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveMost ovarian cancer (OC) patients are diagnosed at a late stage with poor survival. Factors that enable early-stage diagnoses are poorly understood; this study explores differences in pre-diagnostic healthcare utilization for relevant symptoms and diagnoses to identify factors potentially impacting stage at diagnosis.
methodsWe identified OC patients in the North Carolina state cancer registry (2009-2019) with linked multi-payer insurance claims in the year pre-diagnosis. We compared frequency of claims for symptoms of OC and diagnoses often initially ascribed to them, including anxiety, menopausal symptoms, and gastrointestinal disorders, during the month before OC diagnosis and earlier (1-12 months before), stratified by early vs. late-stage.
resultsOut of 2495 patients, 822 (33 %) were diagnosed at an early stage. On the absolute scale, patients with an early stage were nearly twice as likely to present with pelvic pain during the month pre-diagnosis (20 % (95 % CI:(17 %-23 %) vs.11 % (95 % CI:10-13 %)), with patients with late stage more frequently presenting with abdominal and gastrointestinal complaints. In the year pre-diagnosis, 54 % (95 % CI:51-57 %) of patients with early-stage and 52 % (95 % CI:50-54 %) with late-stage were diagnosed with a gastrointestinal disorder, most commonly gastroesophageal reflux disease (GERD). Over 20 % had healthcare encounters for a symptom or related diagnosis as early as 10 months before OC diagnosis.
conclusionsDifferences in symptomatic presentation may explain some early-stage diagnoses, though these were minor. Gastrointestinal disorder diagnoses such as GERD may be an underappreciated hallmark of the pathway to OC diagnosis and should be considered when assessing time to diagnosis using claims.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.